Enabling adoption of 2D-NMR for the higher order structure assessment of monoclonal antibody therapeutics

Journal Article
mAbs, vol. 11, iss. 1, pp. 94-105, 2018
Authors
Robert G. Brinson, John P. Marino, Frank Delaglio, Luke W. Arbogast, Ryan M. Evans, Anthony Kearsley, Geneviève Gingras, Houman Ghasriani, Yves Aubin, Gregory K. Pierens, Xinying Jia, Mehdi Mobli, Hamish G. Grant, David W. Keizer, Kristian Schweimer, Jonas Ståhle, Göran Widmalm, Edward R. Zartler, Chad W. Lawrence, Patrick N. Reardon, John R. Cort, Ping Xu, Feng Ni, Saeko Yanaka, Koichi Kato, Stuart R. Parnham, Desiree Tsao, Andreas Blomgren, Torgny Rundlöf, Nils Trieloff, Peter Schmieder, Alfred Ross, Ken Skidmore, Kang Chen, David Keire, Darón I. Freedberg, Thea Suter-Stahel, Gerhard Wider, Gregor Ilc, Janez Plavec, Scott A. Bradley, Donna M. Baldisseri, Mauricio Luis Sforça, Ana Carolina de Mattos Zeri, Julie Yu Wei, Christina M. Szabo, Carlos A. Amezcua, John B. Jordan, Mats Wikström
English